Divi’s Lab Q3FY23 preview: Consolidated net profit to likely drop 44% YoY
The company’s consolidated revenue will see a drop of 21% YoY, at Rs 1,980 crore. The YoY decline in sales is attributed to the slowing down of Molnupiravir sales as COVID cases fall. Read More The company’s consolidated revenue will… Read More »Divi’s Lab Q3FY23 preview: Consolidated net profit to likely drop 44% YoY









